Testosterone for low libido in postmenopausal women not taking estrogen.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  New England Journal of Medicine

• Publication date

  2008-11-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMoa0707302PMID 18987368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial

  2008cited by this paper
• Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy.

  2008cited by this paper
• Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial.

  2008cited by this paper
• Effects of testosterone treatment on endometrial proliferation in postmenopausal women.

  2007cited by this paper
• Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk.

  2007cited by this paper
• Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women

  2007cited by this paper
• Methods to determine the minimum important difference for a sexual event diary used by postmenopausal women with hypoactive sexual desire disorder.

  2007cited by this paper
• Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.

  2007cited by this paper
• Effects of intranasal 17&bgr;-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women

  2006cited by this paper
• Circulating Androgen Levels and Self-reported Sexual Function in Women

  2006cited by this paper
• Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial

  2006cited by this paper
• Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study

  2006influential reference
• Androgen therapy in women: an Endocrine Society Clinical Practice guideline.

  2006cited by this paper
• Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS)

  2006cited by this paper
• Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.

  2006influential reference
• Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.

  2005influential reference
• Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.

  2005cited by this paper
• Androgen levels in adult females: changes with age, menopause, and oophorectomy.

  2005cited by this paper
• The social and cultural context of sexual function among middle-aged women.

  2005cited by this paper
• Profile of Female Sexual Function: a patient-based, international, psychometric instrument for the assessment of hypoactive sexual desire in oophorectomized women

  2004cited by this paper
• Testosterone effects on the breast: implications for testosterone therapy for women.

  2004cited by this paper
• Validation of the Profile of Female Sexual Function (PFSF) in Surgically and Naturally Menopausal Women

  2004cited by this paper
• The effects of postmenopausal hormone therapies on female sexual functioning: a review of double-blind, randomized controlled trials

  2004cited by this paper
• ORIGINAL RESEARCH—EPIDEMIOLOGY: A Swedish Telephone Help‐line for Sexual Problems: A 5‐year Survey

  2004cited by this paper
• Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women. A randomized controlled trial

  2003cited by this paper
• Sexual function problems and help seeking behaviour in Britain: national probability sample survey

  2003cited by this paper
• Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.

  2002cited by this paper
• Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

  2002cited by this paper
• Are changes in sexual functioning during midlife due to aging or menopause?

  2001cited by this paper
• Non‐parametric analysis of covariance for confirmatory randomized clinical trials to evaluate dose–response relationships

  2001cited by this paper
• Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.

  2000cited by this paper
• Testosterone inhibits estrogen‐induced mammary epithelial proliferation and suppresses estrogen receptor expression

  2000cited by this paper
• Sexual dysfunction in the United States: prevalence and predictors.

  1999cited by this paper
• Sexual disabilities, problems and satisfaction in 18-74 year old Swedes.

  1999cited by this paper
• Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

  1998cited by this paper
• Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality.

  1995cited by this paper
• Psychological reactions and sexual life after hysterectomy with and without oophorectomy.

  1992cited by this paper
• Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.

  1991cited by this paper
• A longitudinal study of the effects of menopause on sexuality.

  1985cited by this paper
• Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.

  1984cited by this paper
• Sexual response after hysterectomy-oophorectomy: recent studies and reconsideration of psychogenesis.

  1981cited by this paper
• Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood.

  1974cited by this paper
• Familial Study of Hirsutism

  1970cited by this paper
• Familial study of hirsutism.

  1970cited by this paper

• Cardiovascular mortality associated with testosterone therapy in cisgender women and transgender men: a systematic review.

  2026cites this paper
• Management of sexual dysfunction in menopause: an update on evidence-based strategies

  2025cites this paper
• Testosterone Pellets in Women: Revisiting Safety and Clinical Outcomes

  2025cites this paper
• Combining Exercise Training and Testosterone Therapy in Older Women After Hip Fracture

  2025cites this paper
• Biological and Cognitive-Behavioral Etiology and Treatment of Female Orgasmic Disorder: A Narrative Review

  2025cites this paper
• Associations between menstrual cycle phases and sexuality, well-being and mood in young healthy women.

  2025cites this paper
• Menopausal hormone therapy for breast cancer patients: what is the current evidence?

  2025cites this paper
• Disfunzioni sessuali

  2025cites this paper
• Testosterone for the Treatment of Hypoactive Sexual Desire Disorder in Perimenopausal and Postmenopausal Women.

  2025cites this paper
• Voice Change as a Result of Androgen Supplementation in Cisgender Women: A Scoping Review

  2025influential citation
• Properties of testosterone transdermal gel in restoring serum testosterone levels in critically ill patients: the TestICU-1 pilot study.

  2025cites this paper
• Disfunciones sexuales

  2025cites this paper
• In postmenopausal female patients, how effective is testosterone for low libido?

  2025cites this paper
• Testosterone and pre-androgens by age and menopausal stage at midlife: findings from a cross-sectional study

  2025cites this paper
• Breast and cervical cancer in transgender men: literature review and a case report

  2024cites this paper
• Sharing the multidisciplinary clinical approach to peri‐ and postmenopausal women: A Delphi consensus among Italian gynecologists, endocrinologists, and cardiologists for an integrated and optimal approach to clinical practice

  2024cites this paper
• Menopause und Sport

  2024cites this paper
• Systemic testosterone for the treatment of female sexual interest and arousal disorder (FSIAD) in the postmenopause

  2024cites this paper
• Sexual Desire and Pharmacologic Management.

  2024cites this paper
• Challenges of prescribing testosterone for sexual dysfunction in women: Number 7 – 2024

  2024influential citation
• Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review

  2024cites this paper
• Dermatological Changes during Menopause and HRT: What to Expect?

  2024cites this paper
• Sexual Dysfunction in Women.

  2024cites this paper
• Testosterone for Treating Female Sexual Dysfunction

  2024influential citation
• Sexual function and fertility in young female adults surgically treated for anorectal malformations

  2024cites this paper
• Characteristics of systemic testosterone therapy for female hypoactive sexual desire disorder-a claims database analysis.

  2024cites this paper
• Testosterone use for hypoactive sexual desire disorder in postmenopausal women.

  2023cites this paper
• Clinical management of androgen excess and defect in women

  2023cites this paper
• Management of perimenopausal and menopausal symptoms

  2023cites this paper
• Effects of oral Shilajit tablets on sexual function and sexual quality of life among reproductive-aged women: a triple-blind randomized clinical trial

  2023cites this paper
• Testosterone and the heart: friend or foe?

  2023cites this paper
• Androgen-based therapies in women.

  2023cites this paper
• Cardiovascular Safety and Benefits of Testosterone Implant Therapy in Postmenopausal Women: Where Are We?

  2023cites this paper
• Preparation and In Vitro and In Vivo Evaluation of a Testosterone Film Forming Gel for the Treatment of Hypoactive Sexual Desire Disorder in Women

  2022cites this paper
• Haematological actions of androgens.

  2022cites this paper
• Use of androgens at different stages of life: climacterium

  2022cites this paper
• Sexual dysfunction with major depressive disorder and antidepressant treatments: impact, assessment, and management

  2022cites this paper
• Menopause transition: Physiology and symptoms.

  2022cites this paper
• Efficacious Androgen Hormone Administration in Combination with Adeno-Associated Virus Vector-Mediated Gene Therapy in Female Mice with Pompe Disease

  2022cites this paper
• Androgens in postmenopausal women

  2022cites this paper
• Testosterone for women: certainties and uncertainties

  2022cites this paper
• The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review

  2022cites this paper
• [Efficacy and safety of testosterone in the treatment of hypoactive sexual desire in women: what does the evidence say?]

  2022cites this paper
• Menopause: Questions and Answers for Improving Homeopathic Clinical Practice

  2022cites this paper
• A Personal Prospective on Testosterone Therapy in Women—What We Know in 2022

  2022cites this paper
• Sexual Dysfunction and Disability

  2021cites this paper
• Sexual Function in Women With Differences of Sex Development or Premature Loss of Gonadal Function.

  2021cites this paper
• ESSM Position Statement “Sexual Wellbeing After Gender Affirming Surgery”

  2021cites this paper
• International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women

  2021cites this paper
• Androgen therapy for women after menopause.

  2021cites this paper
• Testosterone in Females

  2021cites this paper
• Effect of Zinc on Testosterone Levels and Sexual Function of Postmenopausal Women: A Randomized Controlled Trial

  2021cites this paper
• The Role of Androgens in Women's Health and Wellbeing.

  2021cites this paper
• Current use of testosterone therapy in LGBTQ populations

  2021cites this paper
• Testosterone-induced increase in libido in a patient with a loss-of-function mutation in the AR gene

  2021cites this paper
• Sexual Health and Function in Menopause and Beyond

  2021cites this paper
• A multi-center trial of exercise and testosterone therapy in women after hip fracture: Design, methods and impact of the COVID-19 pandemic

  2021cites this paper
• The testosterone prescribing practice of BMS menopause specialists

  2021cites this paper
• Risks of Testosterone for Postmenopausal Women.

  2021cites this paper
• International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women

  2021cites this paper
• Use of Testosterone in Postmenopausal Women.

  2021cites this paper
• Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004

  2021cites this paper
• Sexual Dysfunctions in Women: Are Androgens at Fault?

  2021cites this paper
• Androgens in premenopausal women and women with premature ovarian insufficiency

  2021cites this paper
• International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.

  2021influential citation
• Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians

  2021cites this paper
• A direct comparison of women’s perceptions and acceptability of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol in the management of young postmenopausal women, under 45 years of age

  2020cites this paper
• The Menopause Transition: Signs, Symptoms, and Management Options.

  2020cites this paper
• THE KOREAN SOCIETY OF MENOPAUSE PAGES

  2020cites this paper
• Testosterone use in postmenopausal women

  2020cites this paper
• The 2020 Menopausal Hormone Therapy Guidelines

  2020cites this paper
• Olfactory Exposure to β-Caryophyllene Increases Testosterone Levels in Women's Saliva

  2020cites this paper
• The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women

  2020cites this paper
• The Saga of Testosterone for Menopausal Women at the Food and Drug Administration (FDA).

  2020cites this paper
• The Protective Effect of Testosterone on the Ovarian Reserve During Cyclophosphamide Treatment

  2020cites this paper
• Menopause

  2020cites this paper
• OTT_A_242703 2987..2995

  2020cites this paper
• Female Sexual Function and Dysfunction

  2020cites this paper
• Voice Change Following Testosterone Supplementation in Women: A Multi-Institutional Case Series.

  2020cites this paper
• Testosterone therapy and other treatment modalities for female sexual dysfunction.

  2020cites this paper
• Androgen Therapy in Women

  2020cites this paper
• The role of testosterone in menopausal hormone treatment. What is the evidence?

  2020cites this paper
• Methodological Challenges in Studying Testosterone Therapies for Hypoactive Sexual Desire Disorder in Women.

  2020cites this paper
• Androgen Therapy for Postmenopausal Women

  2020cites this paper
• Female Sexual Dysfunction: Pharmacologic and Therapeutic Interventions.

  2020cites this paper
• Prescribing testosterone and DHEA: The role of androgens in women

  2020cites this paper
• Effects of testosterone therapy for women: a systematic review and meta-analysis protocol

  2019cites this paper
• Sexual Function Under Adequate Estrogen Therapy in Women After Oophorectomy Versus Natural Menopause

  2019cites this paper
• Tratamiento de la esclerosis múltiple

  2019cites this paper
• Title Exposure to Essential Oil Odors Increases Salivary TestosteroneConcentration in Perimenopausal Women

  2019cites this paper
• Sexual Function in Postmenopausal Women and Serum Androgens: A Review Article

  2019cites this paper
• Testosterone Prescribing Among Women in the USA, 2002–2017

  2019cites this paper
• Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism

  2019cites this paper
• Chapitre 8 : Sexualité et ménopause.

  2019cites this paper
• Female Sexual Dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213.

  2019cites this paper
• Is testosterone involved in low female sexual desire?

  2019cites this paper
• Endokrine Aspekte bei Libidostörungen

  2019cites this paper
• Exposure to Essential Oil Odors Increases Salivary Testosterone Concentration in Perimenopausal Women.

  2019cites this paper
• Female Sexual Dysfunction: ACOG Practice Bulletin Summary, NUMBER 213.

  2019cites this paper
• A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women

  2019cites this paper